FOXO4-DRI — dosage, half-life & reference guide

Longevity peptide · also known as FOXO4-p53 DRI peptide, Senostatic peptide

An experimental senolytic peptide — it selectively triggers the death of "zombie cells" (senescent cells) that accumulate with age and release inflammatory signals. FOXO4-DRI disrupts the survival mechanism these damaged cells use to avoid being cleared. Very early-stage and used in short, infrequent cycles.

Commonly-researched dose ranges

FOXO4-DRI is commonly researched at 1–2 mg, 3x/week (short cycles), by SubQ injection. These are reference ranges from the literature and community use, not a prescription.

Half-life

Estimated half-life: Hours. See how it accumulates in the half-life calculator.

Safety & interactions

Commonly reported effects: fatigue, flu-like symptoms, transient weakness, hair thinning (reported). Discuss with your clinician.

Open the full FOXO4-DRI guide (needs JavaScript). PepVault is a private research and tracking tool, not medical advice.